Design, synthesis and evaluation of small molecule imidazo[2,1-b][1,3,4]thiadiazoles as inhibitors of transforming growth factor-β type-I receptor kinase (ALK5)-Reference-Cited by-同舟云学术

Design, synthesis and evaluation of small molecule imidazo[2,1-b][1,3,4]thiadiazoles as inhibitors of transforming growth factor-β type-I receptor kinase (ALK5)

Published:2015-03 Issue: Volume:93 Page:599-613
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Patel Harun M.,Sing Baljeet,Bhardwaj Varun,Palkar Mahesh,Shaikh Mahamadhanif S.,Rane Rajesh,Alwan Wesam S.,Gadad Andanappa K.,Noolvi Malleshappa N.,Karpoormath Rajshekhar

Funder

Gujarat Council on Science and Technology, Gandhinagar

National Research Foundation, South Africa

College of Health Sciences, University of KwaZulu-Natal, South Africa

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference21 articles.

1. 2-Aminoimidazoles inhibitors of TGF-β receptor 1

2. The TGFβ Receptor Activation Process

3. Two major Smad pathways in TGF-β superfamily signalling

4. TGF-β SIGNAL TRANSDUCTION

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors;Bioorganic Chemistry;2024-06

2. Small-molecule modulators of tumor immune microenvironment;Bioorganic Chemistry;2024-04

3. Design, Synthesis, and In Vitro Antiproliferative Activity of 4,5,6-Trisubstituted 2-Aminopyrimidines as Potential TGF-β Inhibitors;Russian Journal of Organic Chemistry;2024-04

4. Synthesis, Luminescence and Relaxometric Properties of Macrocyclic Lanthanide Complexes Appended with an Imidazothiadiazole, a Heterocyclic Bioactive Scaffold;European Journal of Inorganic Chemistry;2024-01-29

5. Investigation of Ln³⁺ complexation by a DOTA derivative substituted by an imidazothiadiazole: synthesis, solution structure, luminescence and relaxation properties;Dalton Transactions;2024